ENTRADA THERAPEUTICS, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-96.5% -$36M
$1M
R&D↑+1.6% +$551K
$34M
D&A↓-10.7% -$106K
$886K
Operating Income↓-117.2% -$25M
$-47M
EBITDA↓-10.7% -$106K
$886K
Tax Provision
$92K
Net Income↓-214.5% -$30M
$-44M
Operating Margin↓-2804.5pts
-2915.2%
Net Margin↓-2662.7pts
-2734.4%
ETR (Continuing Operations)↓-1.9pts
-0.6%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+3.6pts
6.8%
Operating Lease Cost↓-16.0% -$485K
$3M
Revenue YoY Variation↓-85.9pts
-96.5%
Income YoY Variation↑+137.3pts
-117.2%
Revenue QoQ Variation↓-110.6pts
-19.5%
Income QoQ Variation↑+140.1pts
-0.4%